Our data suggest that rs721048 may be associated with prostate cancer through the disruption of the mechanism of action of certain tumor-specific enhancers causing the dysregulation of the expression of OTX1 and EHBP1 genes. This evidence concerns the gene OTX1 and prostate carcinoma.